SomaLogic to Receive Up to $60.5M in Funds From Visium | GenomeWeb

NEW YORK (GenomeWeb) – SomaLogic said today that it will receive up to $60.5 million in debt and equity financing from Visium Healthcare Partners.

The company said it plans to use the funds to support the development of new life science tools and clinical diagnostics based on its Somamer affinity agent technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.